data.cms.govHand-written summary
Medicare Part B Spending by Drug
Medicare Part B spending on drugs given in doctors' offices and other outpatient settings, with average spending per dosage unit and change over time.
Freshness
- Last posted
- Period covered
- Jan 1, 2024 to Dec 31, 2024
- Update frequency
- Annually
Dates as CMS lists them in its catalog.
Before you use it
- Metrics are calculated at the HCPCS code level and include both the Medicare payment and what the patient owes.
Columns 47
| Column | What it means | Type |
|---|---|---|
Medicare Billing Code (HCPCS Code)HCPCS_Cd | Healthcare Common Procedure Coding System (HCPCS) code used to identify the drug furnished by the provider. | string |
Drug DescriptionHCPCS_Desc | Description of the HCPCS code for the drug furnished by the provider. | string |
Brand NameBrnd_Name | Name of the drug furnished by the provider. This includes both brand names (drugs that have a trademarked name) and generic names (drugs that do not have a trademarked name). ' * ' Indicates multiple brand and/or generic names for a specific HCPCS code. See “Medicare Part B Spending by Drug-Manufacturer and Drug Use Information” supporting document for additional names. ' ** ' Indicates brand/generic names unavailable. Name reflects the HCPCS short description. | string |
Generic NameGnrc_Name | A term referring to the chemical ingredient of a drug rather than the trademarked brand name under which the drug is sold. ' * ' Indicates multiple brand and/or generic names for a specific HCPCS code. See “Medicare Part B Spending by Drug-Manufacturer and Drug Use Information” supporting document for additional names. ' ** ' Indicates brand/generic names unavailable. Name reflects the HCPCS short description. | string |
2020 Total SpendingTot_Spndng_2020 | Aggregate drug spending for the Part B program during 2020. | number |
2020 Total Dosage UnitsTot_Dsg_Unts_2020 | The sum of the dosage units of medication dispensed in 2020 (e.g. number of tablets, grams, milliliters or other units). For Part B, the quantity of a drug in a dosage unit is the same as the quantity of the drug in a HCPCS billing unit. | number |
2020 Total ClaimsTot_Clms_2020 | Number of claims for each drug in 2020. | number |
2020 Total BeneficiariesTot_Benes_2020 | Number of Medicare Part B fee-for-service beneficiaries utilizing the drug during 2020. | number |
2020 Average Spending Per Dosage UnitAvg_Spndng_Per_Dsg_Unt_2020 | Part B drug spending in 2020 divided by the number of dosage units in 2020. | number |
2020 Average Spending Per ClaimAvg_Spndng_Per_Clm_2020 | Part B drug spending in 2020 divided by the number of claims in 2020. | number |
2020 Average Spending Per BeneficiaryAvg_Spndng_Per_Bene_2020 | Total Part B drug costs in 2020 divided by the number of unique beneficiaries utilizing the drug during 2020. | number |
2020 Outlier FlagOutlier_Flag_2020 | Yearly outlier flag variable, which is set to “1” when a drug’s Average Spending per Dosage Unit is substantially impacted by outlier records in a given year. These potentially anomalous drugs are identified as outliers so that users can exercise caution when interpreting results. See the methodology document for additional details. | number |
2021 Total SpendingTot_Spndng_2021 | Aggregate drug spending for the Part B program during 2021. | number |
2021 Total Dosage UnitsTot_Dsg_Unts_2021 | The sum of the dosage units of medication dispensed in 2021 (e.g. number of tablets, grams, milliliters or other units). For Part B, the quantity of a drug in a dosage unit is the same as the quantity of the drug in a HCPCS billing unit. | number |
2021 Total ClaimsTot_Clms_2021 | Number of claims for each drug in 2021. | number |
2021 Total BeneficiariesTot_Benes_2021 | Number of Medicare Part B fee-for-service beneficiaries utilizing the drug during 2021. | number |
2021 Average Spending Per Dosage UnitAvg_Spndng_Per_Dsg_Unt_2021 | Part B drug spending in 2021 divided by the number of dosage units in 2021. | number |
2021 Average Spending Per ClaimAvg_Spndng_Per_Clm_2021 | Part B drug spending in 2021 divided by the number of claims in 2021. | number |
2021 Average Spending Per BeneficiaryAvg_Spndng_Per_Bene_2021 | Total Part B drug costs in 2021 divided by the number of unique beneficiaries utilizing the drug during 2021. | number |
2021 Outlier FlagOutlier_Flag_2021 | Yearly outlier flag variable, which is set to “1” when a drug’s Average Spending per Dosage Unit is substantially impacted by outlier records in a given year. These potentially anomalous drugs are identified as outliers so that users can exercise caution when interpreting results. See the methodology document for additional details. | number |
2022 Total SpendingTot_Spndng_2022 | Aggregate drug spending for the Part B program during 2022. | number |
2022 Total Dosage UnitsTot_Dsg_Unts_2022 | The sum of the dosage units of medication dispensed in 2022 (e.g. number of tablets, grams, milliliters or other units). For Part B, the quantity of a drug in a dosage unit is the same as the quantity of the drug in a HCPCS billing unit. | number |
2022 Total ClaimsTot_Clms_2022 | Number of claims for each drug in 2022. | number |
2022 Total BeneficiariesTot_Benes_2022 | Number of Medicare Part B fee-for-service beneficiaries utilizing the drug during 2022. | number |
2022 Average Spending Per Dosage UnitAvg_Spndng_Per_Dsg_Unt_2022 | Part B drug spending in 2022 divided by the number of dosage units in 2022. | number |
2022 Average Spending Per ClaimAvg_Spndng_Per_Clm_2022 | Part B drug spending in 2022 divided by the number of claims in 2022. | number |
2022 Average Spending Per BeneficiaryAvg_Spndng_Per_Bene_2022 | Total Part B drug costs in 2022 divided by the number of unique beneficiaries utilizing the drug during 2022. | number |
2022 Outlier FlagOutlier_Flag_2022 | Yearly outlier flag variable, which is set to “1” when a drug’s Average Spending per Dosage Unit is substantially impacted by outlier records in a given year. These potentially anomalous drugs are identified as outliers so that users can exercise caution when interpreting results. See the methodology document for additional details. | number |
2023 Total SpendingTot_Spndng_2023 | Aggregate drug spending for the Part B program during 2023. | number |
2023 Total Dosage UnitsTot_Dsg_Unts_2023 | The sum of the dosage units of medication dispensed in 2023 (e.g. number of tablets, grams, milliliters or other units). For Part B, the quantity of a drug in a dosage unit is the same as the quantity of the drug in a HCPCS billing unit. | number |
2023 Total ClaimsTot_Clms_2023 | Number of claims for each drug in 2023. | number |
2023 Total BeneficiariesTot_Benes_2023 | Number of Medicare Part B fee-for-service beneficiaries utilizing the drug during 2023. | number |
2023 Average Spending Per Dosage UnitAvg_Spndng_Per_Dsg_Unt_2023 | Part B drug spending in 2023 divided by the number of dosage units in 2023. | number |
2023 Average Spending Per ClaimAvg_Spndng_Per_Clm_2023 | Part B drug spending in 2023 divided by the number of claims in 2023. | number |
2023 Average Spending Per BeneficiaryAvg_Spndng_Per_Bene_2023 | Total Part B drug costs in 2023 divided by the number of unique beneficiaries utilizing the drug during 2023. | number |
2023 Outlier FlagOutlier_Flag_2023 | Yearly outlier flag variable, which is set to “1” when a drug’s Average Spending per Dosage Unit is substantially impacted by outlier records in a given year. These potentially anomalous drugs are identified as outliers so that users can exercise caution when interpreting results. See the methodology document for additional details. | number |
2024 Total SpendingTot_Spndng_2024 | Aggregate drug spending for the Part B program during 2024. | number |
2024 Total Dosage UnitsTot_Dsg_Unts_2024 | The sum of the dosage units of medication dispensed in 2024 (e.g. number of tablets, grams, milliliters or other units). For Part B, the quantity of a drug in a dosage unit is the same as the quantity of the drug in a HCPCS billing unit. | number |
2024 Total ClaimsTot_Clms_2024 | Number of claims for each drug in 2024. | number |
2024 Total BeneficiariesTot_Benes_2024 | Number of Medicare Part B fee-for-service beneficiaries utilizing the drug during 2024. | number |
2024 Average Spending Per Dosage UnitAvg_Spndng_Per_Dsg_Unt_2024 | Part B drug spending in 2024 divided by the number of dosage units in 2024. | number |
2024 Average Spending Per ClaimAvg_Spndng_Per_Clm_2024 | Part B drug spending in 2024 divided by the number of claims in 2024. | number |
2024 Average Spending Per BeneficiaryAvg_Spndng_Per_Bene_2024 | Total Part B drug costs in 2024 divided by the number of unique beneficiaries utilizing the drug during 2024. | number |
2024 Outlier FlagOutlier_Flag_2024 | Yearly outlier flag variable, which is set to “1” when a drug’s Average Spending per Dosage Unit is substantially impacted by outlier records in a given year. These potentially anomalous drugs are identified as outliers so that users can exercise caution when interpreting results.See the methodology document for additional details. | number |
Average Sales PriceAvg_DY24_ASP_Price | The average of the quarterly payment amount listed on the ASP Drug Pricing files for the most recent year, including the 6 percent or other applicable add-on. | number |
Change in Average Spending Per Dosage Unit (2023-2024)Chg_Avg_Spndng_Per_Dsg_Unt_23_24 | The percent change in average spending per dosage unit from the prior year. | number |
Annual Growth Rate in Average Spending Per Dosage Unit (2020-2024)CAGR_Avg_Spnd_Per_Dsg_Unt_20_24 | The constant average change in spending per unit over the most recent five years of data availability, calculated using the compound annual growth rate (CAGR). | number |
No column matches that filter.
At a glance
- Catalog
- data.cms.gov
- Publisher
- Office of Enterprise Data and Analytics (OEDA)
- Rows
- 799
- Columns
- 47
- State column
- None found
API
Free, no key needed. This request returns the first 10 rows as JSON:
https://data.cms.gov/data-api/v1/dataset/76a714ad-3a2c-43ac-b76d-9dadf8f7d890/data?size=10
CMS's description
The Medicare Part B by Drug dataset presents information on spending for drugs administered in doctors’ offices and other outpatient settings by physicians and other healthcare providers to Medicare Part B enrollees. The dataset focuses on average spending per dosage unit and change in average spending per dosage unit over time. It also includes consumer-friendly descriptions of the drug uses, clinical indications, and manufacturer(s). Drug spending metrics for Part B drugs represent the full value of the product, including the Medicare payment and beneficiary liability. All Part B drug spending metrics are calculated at the HCPCS level.
Methodology and other documents from CMS:
The summary at the top was written by hand from this description. Record id cms:76a714ad-3a2c-43ac-b76d-9dadf8f7d890. This record as JSON.